International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 1 , Pages 225-234 , 1 September 2009

Modulation of Ionizing Radiation-Induced G2 Arrest by Cyclooxygenase-2 and its Inhibitor Celecoxib

  • Hyun Jung Jun, M.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Young Mee Kim, Ph.D.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Soo Yeon Park, B.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Ji Sun Park, M.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA
    • ,
  • Eun Jung Lee, M.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Shin Ae Choi, M.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Hongryull Pyo, M.D., Ph.D.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • Corresponding Author InformationReprint requests to: Hongryull Pyo, M.D., Ph.D., Research Institute and Hospital, National Cancer Center, 809 Madu-1-dong, ILsandong-gu, Goyang-si, Gyeonggi-do, 410-769, Republic of Korea. Tel: (+82) 31-920-1723; Fax: (+82) 31-920-0149

Received 3 January 2009 ,Revised 15 April 2009 ,Accepted 23 April 2009.

References 

  1. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem. 1991;60:281–319
  2. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18:7908–7916
  3. Pyo H, DuBois RN, Choy H. The role of cyclooxygenase-2 inhibitors in combined modality therapy. In:  Choy H editors. Chemoradiation in cancer therapy. Totowa, NJ: Humana Press; 2003;p. 391–408
  4. Pyo H, Choy H, Amorino GP, et al. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res. 2001;7:2998–3005
  5. Shin YK, Park JS, Kim HS, et al. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Cancer Res. 2005;65:9501–9509
  6. Hwang A, Muschel RJ. Radiation and the G2 phase of the cell cycle. Radiat Res. 1998;150(Suppl. 5):S52–S59
  7. Kang HK, Lee E, Pyo H, et al. Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells. Mol Cancer Ther. 2005;4:1358–1363
  8. Di Micco R, Fumagalli M, Cicalese A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444:638–642
  9. Xu B, Kim ST, Lim DS, et al. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol. 2002;22:1049–1059
  10. Wang X, Khadpe J, Hu B, et al. An overactivated ATR/CHK1 pathway is responsible for the prolonged G2 accumulation in irradiated AT cells. J Biol Chem. 2003;278:30869–30874
  11. Wilson GD. Radiation and the cell cycle, revisited. Cancer Metastasis Rev. 2004;23:209–225
  12. Brown EJ, Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 2003;17:615–628
  13. Yang J, Yu Y, Hamrick HE, et al. ATM, ATR and DNA-PK: Initiators of the cellular genotoxic stress responses. Carcinogenesis. 2003;24:1571–1580
  14. Goodarzi AA, Block WD, Lees-Miller SP. The role of ATM and ATR in DNA damage-induced cell cycle control. Prog Cell Cycle Res. 2003;5:393–411
  15. Yang J, Xu ZP, Huang Y, et al. ATM and ATR: Sensing DNA damage. World J Gastroenterol. 2004;10:155–160
  16. Milas L, Kishi K, Hunter N, et al. Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. J Natl Cancer Inst. 1999;91:1501–1504
  17. Kishi K, Petersen S, Petersen C, et al. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res. 2000;60:1326–1331
  18. Petersen C, Petersen S, Milas L, et al. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res. 2000;6:2513–2520
  19. Raju U, Nakata E, Yang P, et al. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: Mechanistic considerations. Int J Radiat Oncol Biol Phys. 2002;54:886–894
  20. Shah T, Ryu S, Lee HJ, et al. Pronounced radiosensitization of cultured human cancer cells by COX inhibitor under acidic microenvironment. Int J Radiat Oncol Biol Phys. 2002;53:1314–1318
  21. Amirghahari N, Harrison L, Smith M, et al. NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2. Int J Radiat Oncol Biol Phys. 2003;57:1405–1412
  22. Wen B, Deutsch E, Eschwege P, et al. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. J Urol. 2003;170:2036–2039
  23. Nakata E, Mason KA, Hunter N, et al. Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors. Int J Radiat Oncol Biol Phys. 2004;58:369–375
  24. Iliakis G, Wang Y, Guan J, et al. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene. 2003;22:5834–5847
  25. Hurley PJ, Bunz F. ATM and ATR: Components of an integrated circuit. Cell Cycle. 2007;6:414–417
  26. Syljuasen RG, Jensen S, Bartek J, et al. Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases. Cancer Res. 2006;66:10253–10257
  27. Hurley PJ, Wilsker D, Bunz F. Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation. Oncogene. 2007;26:2535–2542
  28. Anderson HJ, Andersen RJ, Roberge M. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy. Prog Cell Cycle Res. 2003;5:423–430
  29. Tenzer A, Pruschy M. Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators. Curr Med Chem Anticancer Agents. 2003;3:35–46

 This work was supported by the National Cancer Center (Grant No. 0710380-2).

 H.J.J. is currently at the Department of Neurosurgery and Molecular Oncology Research Institute, Tuffs Medical Center, Boston, MA.

 Conflict of interest none.

PII: S0360-3016(09)00720-2

doi: 10.1016/j.ijrobp.2009.04.086

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 1 , Pages 225-234 , 1 September 2009

Article Tools

* Image Usage & Resolution